White Paper on studying the safety of the childhood immunization schedule in the Vaccine Safety Datalink

Vaccine
Jason GlanzM F Daley

Abstract

While the large majority of parents in the U.S. vaccinate their children according to the recommended immunization schedule, some parents have refused or delayed vaccinating, often citing safety concerns. In response to public concern, the U.S. Institute of Medicine (IOM) evaluated existing research regarding the safety of the recommended immunization schedule. The IOM concluded that although available evidence strongly supported the safety of the currently recommended schedule as a whole, additional observational research was warranted to compare health outcomes between fully vaccinated children and those on a delayed or alternative schedule. In addition, the IOM identified the Vaccine Safety Datalink (VSD) as an important resource for conducting this research. Guided by the IOM findings, the Centers for Disease Control and Prevention (CDC) commissioned a White Paper to assess how the VSD could be used to study the safety of the childhood immunization schedule. Guided by subject matter expert engagement, the resulting White Paper outlines a 4 stage approach for identifying exposure groups of undervaccinated children, presents a list of health outcomes of highest priority to examine in this context, and describes various study ...Continue Reading

References

Mar 1, 1976·Physics in Medicine and Biology·D E Raeside
Jan 1, 1991·Journal of Clinical Epidemiology·M Maclure
Jul 1, 1997·Archives of Pediatrics & Adolescent Medicine·R K ZimmermanT A Mieczkowski
Jan 15, 1999·Epidemiology·S GreenlandJ M Robins
Oct 16, 1999·American Journal of Epidemiology·J J WeinkamT D Sterling
Nov 4, 2000·Pediatrics·B G GellinE K Marcuse
Jul 20, 2001·Thorax·M M HabyS R Leeder
Aug 17, 2002·The Pediatric Infectious Disease Journal·Frank DeStefanoUNKNOWN Vaccine Safety Datalink Research Group
Mar 23, 2004·American Journal of Epidemiology·Guangyong Zou
Mar 10, 2005·JAMA : the Journal of the American Medical Association·Elizabeth T LumanLarry K Pickering
Jul 1, 2005·American Journal of Epidemiology·Til StürmerRobert J Glynn
Oct 13, 2005·Statistics in Medicine·Heather J WhitakerPatrick Musonda
Dec 16, 2005·Chest·Pamela Sangeloty HigginsMichelle M Cloutier
Jun 17, 2006·American Journal of Preventive Medicine·Deborah A GustBenjamin Schwartz
Oct 13, 2006·JAMA : the Journal of the American Medical Association·Saad B OmerDaniel A Salmon
Jan 26, 2007·Pharmacoepidemiology and Drug Safety·Samy Suissa
Sep 28, 2007·The New England Journal of Medicine·William W ThompsonUNKNOWN Vaccine Safety Datalink Team
Nov 15, 2007·JAMA : the Journal of the American Medical Association·Sandra W RoushUNKNOWN Vaccine-Preventable Disease Table Working Group
Jan 2, 2008·Pediatrics·UNKNOWN American Academy of Pediatrics Committee on Infectious Diseases
Mar 4, 2008·Pediatrics·Eric K FranceUNKNOWN Vaccine Safety Datalink Team
Apr 17, 2008·Cancer Causes & Control : CCC·D TrichopoulosH O Adami
Oct 3, 2008·Pediatrics·Deborah A GustBen Schwartz
Jul 21, 2009·Vaccine·Irene M ShuiUNKNOWN Vaccine Safety Datalink Research Team
Sep 22, 2009·Vaccine·Allison L NalewayUNKNOWN Vaccine Safety Datalink
Mar 3, 2010·Pediatrics·Gary L FreedMatthew M Davis
Apr 20, 2011·Pediatrics·James BaggsEric Weintraub
Jul 19, 2011·Vaccine·Douglas J OpelDiane Martin
Aug 4, 2011·Archives of Pediatrics & Adolescent Medicine·Jason M GlanzEric S Weintraub
Oct 5, 2011·Pediatrics·Amanda F DempseyGary L Freed
Jan 24, 2012·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·John-Michael GambleDean T Eurich
Jun 20, 2012·Pediatrics·Steve G RobisonCollette Young
Dec 25, 2012·Obstetrics and Gynecology·Stephanie A IrvingUNKNOWN Vaccine Safety Datalink
Jun 27, 2013·Annals of Epidemiology·Anne M Jurek, Sander Greenland
Jul 13, 2013·Pharmacoepidemiology and Drug Safety·Shahed IqbalFrank DeStefano
Nov 29, 2013·The New England Journal of Medicine·Willem G van PanhuisDonald S Burke
Mar 25, 2014·Annals of Internal Medicine·Carolyn B BridgesUNKNOWN Advisory Committee on Immunization Practices

❮ Previous
Next ❯

Citations

Jul 21, 2016·Anales de pediatría : publicación oficial de la Asociación Española de Pediatría (A.E.P.)·Roi Piñeiro PérezIván Carabaño Aguado
Feb 15, 2018·Pharmacoepidemiology and Drug Safety·Shirley V WangMartin Kulldorff
May 17, 2018·Biometrical Journal. Biometrische Zeitschrift·Stanley XuJason M Glanz
Aug 1, 2019·Journal of the American Medical Informatics Association : JAMIA·Sophia R NewcomerJason M Glanz
Feb 8, 2020·The Pediatric Infectious Disease Journal·Sophia R NewcomerJason M Glanz
Jan 3, 2018·Pharmacoepidemiology and Drug Safety·Sophia R NewcomerJason M Glanz
Dec 4, 2020·International Journal of Environmental Research and Public Health·James Lyons-Weiler, Paul Thomas
May 13, 2021·American Journal of Preventive Medicine·Sophia R NewcomerMatthew F Daley
May 1, 2021·Epidemiology·Anne M ButlerM Alan Brookhart
Sep 8, 2021·Frontiers in Pharmacology·Xiao-Feng NiLing-Li Zhang

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.